Related Experiment Video
Updated: Jan 11, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding
Ella W Mathews1,2, Sydney R Coffey2, Annette Gärtner3
1Department of Neurology, University of Washington, Seattle, WA, 98104, USA.
Abstract:
Huntington's disease arises from a CAG expansion in the huntingtin gene beyond a critical threshold. Current therapeutics primarily aim to reduce toxicity by lowering levels of mutant HTT mRNA and protein. Genetic data support a role for somatic instability in HTT's CAG repeat as a driver of age of motor dysfunction onset, but currently, the relationship between instability and HTT lowering remains unexplored. Here, we investigate various HTT-lowering modalities to establish the relationship between HTT lowering and instability in Huntington's disease knock-in mice. We find that repressing transcription of mutant Htt reduces instability, using genetic and pharmacological approaches. Remarkably, zinc finger proteins that target CAG repeats, but lack a repressive domain, protect from somatic instability despite not reducing HTT mRNA or protein levels. These results suggest that DNA-targeted HTT-lowering treatments may have advantages compared to other HTT-lowering approaches, and that steric blockage of CAG repeats may reduce instability while sparing HTT expression.
Insights
Huntington's disease treatments that lower mutant huntingtin (HTT) levels can reduce CAG repeat instability. DNA-targeting strategies show promise for reducing instability without lowering HTT expression.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is caused by a CAG repeat expansion in the huntingtin gene.
- Current HD therapies aim to reduce mutant huntingtin (HTT) mRNA and protein levels.
- Somatic instability of the CAG repeat is implicated in HD motor dysfunction onset.
Purpose of the Study:
- To investigate the relationship between HTT-lowering strategies and CAG repeat instability in HD models.
- To explore whether different HTT-lowering modalities impact somatic instability.
- To assess the potential of DNA-targeting approaches for managing HD.
Main Methods:
- Utilized Huntington's disease knock-in mouse models.
- Employed genetic and pharmacological methods to repress mutant Htt transcription.
- Tested zinc finger proteins targeting CAG repeats for their effect on somatic instability.
Main Results:
- Repressing mutant Htt transcription effectively reduced CAG repeat instability.
- Zinc finger proteins targeting CAG repeats prevented somatic instability without lowering HTT levels.
- These findings establish a link between HTT lowering and CAG repeat instability.
Conclusions:
- HTT-lowering by repressing transcription reduces somatic instability in HD models.
- DNA-targeting strategies, like zinc finger proteins, can mitigate somatic instability independently of HTT reduction.
- Targeting the DNA repeat itself may offer therapeutic advantages for Huntington's disease.
More Related Videos
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Position-effect Variegation